Medical Properties Trust, Inc. (NYSE:MPW) Shares Sold by Ballentine Partners LLC

Ballentine Partners LLC reduced its stake in shares of Medical Properties Trust, Inc. (NYSE:MPW) by 16.5% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 36,765 shares of the real estate investment trust’s stock after selling 7,282 shares during the period. Ballentine Partners LLC’s holdings in Medical Properties Trust were worth $145,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of MPW. Future Financial Wealth Managment LLC acquired a new stake in Medical Properties Trust during the third quarter worth about $29,000. Truvestments Capital LLC purchased a new stake in Medical Properties Trust in the 3rd quarter worth approximately $31,000. GAMMA Investing LLC boosted its position in Medical Properties Trust by 107.3% in the 3rd quarter. GAMMA Investing LLC now owns 6,077 shares of the real estate investment trust’s stock worth $36,000 after purchasing an additional 3,145 shares in the last quarter. Wealthstream Advisors Inc. acquired a new stake in shares of Medical Properties Trust during the 3rd quarter worth approximately $60,000. Finally, Y Intercept Hong Kong Ltd purchased a new position in shares of Medical Properties Trust during the 3rd quarter valued at approximately $61,000. Hedge funds and other institutional investors own 71.79% of the company’s stock.

Analyst Ratings Changes

A number of analysts recently issued reports on the stock. Mizuho lowered their price target on shares of Medical Properties Trust from $6.00 to $5.00 and set a “neutral” rating on the stock in a report on Thursday, December 5th. Truist Financial lowered their target price on shares of Medical Properties Trust from $6.00 to $4.00 and set a “hold” rating on the stock in a research note on Thursday, December 19th. One analyst has rated the stock with a sell rating, six have issued a hold rating and one has assigned a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $4.92.

Medical Properties Trust Stock Up 2.6 %

MPW opened at $4.69 on Monday. The company has a market cap of $2.82 billion, a PE ratio of -1.11, a price-to-earnings-growth ratio of 0.80 and a beta of 1.29. Medical Properties Trust, Inc. has a twelve month low of $3.08 and a twelve month high of $6.55. The company has a 50-day moving average price of $4.09 and a 200 day moving average price of $4.65. The company has a quick ratio of 2.38, a current ratio of 2.38 and a debt-to-equity ratio of 1.69.

Medical Properties Trust Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, January 9th. Stockholders of record on Thursday, December 12th were given a $0.08 dividend. The ex-dividend date of this dividend was Thursday, December 12th. This represents a $0.32 annualized dividend and a dividend yield of 6.82%. Medical Properties Trust’s dividend payout ratio (DPR) is presently -7.58%.

Insider Transactions at Medical Properties Trust

In other Medical Properties Trust news, CAO James Kevin Hanna sold 11,641 shares of the firm’s stock in a transaction on Thursday, December 26th. The stock was sold at an average price of $3.72, for a total value of $43,304.52. Following the transaction, the chief accounting officer now owns 366,913 shares in the company, valued at approximately $1,364,916.36. This trade represents a 3.08 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Corporate insiders own 1.53% of the company’s stock.

Medical Properties Trust Company Profile

Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023.